Fu W - Search Results

1

Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study.

Fu W, Bang SM, Huang H, Kim K, Li W, An G, Lee JJ, Cai Z, Jin J, Wang Y, Lin TL, Chim CS, Qi M, Wang J, Lu X, Song Y, Jia B, Yang X, Liu W, Zhou T, Yin L, Li Y, Zhang R, Hou J, Wang J. Fu W, et al. Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):446-455.e4. doi: 10.1016/j.clml.2023.02.009. Epub 2023 Mar 4. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37024420 Free article. Clinical Trial.

2

[Identification of a novel mutation of human blood coagulation FV gene associated with congenital FV deficiency].

Fu WJ, Hou J, Wang DX, Yu RQ. Fu WJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Mar;24(3):119-21. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12697120 Chinese.

3

[A novel molecular mechanism of congenital FV deficiency: mutation in the intron acceptor splice site of human blood coagulation FV gene].

Fu WJ, Hou J, Wang DX, Yu RQ. Fu WJ, et al. Zhonghua Yi Xue Za Zhi. 2003 Jan 10;83(1):24-6. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12757640 Chinese.

4

[Effects of arsenic trioxide on cell cycle and expression of cyclin dependent kinase inhibitors of multiple myeloma cells].

Chen YB, Fu WJ, Hou J, Ding SQ, Wang DX, Yuan ZG, Kong XT. Chen YB, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Apr;24(4):193-6. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12864950 Chinese.

5

[Establishment of a human CD30+ anaplastic large cell lymphoma cell line and its biological characteristics].

Jiang H, Hou J, Fu WJ, Ding SQ, Zhang B. Jiang H, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003 Oct;11(5):490-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003. PMID: 14575543 Chinese.

6

[Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells].

Chen YB, Hou J, Fu WJ, Ding SQ, Wang DX, Yuan ZG, Kong XT. Chen YB, et al. Ai Zheng. 2003 Dec;22(12):1276-9. Ai Zheng. 2003. PMID: 14693051 Chinese.

7

[Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].

Tao ZF, Fu WJ, Chen YB, Yuan ZG, Wang DX, Hou J. Tao ZF, et al. Ai Zheng. 2006 Apr;25(4):461-4. Ai Zheng. 2006. PMID: 16613681 Chinese.

8

Prognostic factors for the efficacy of thalidomide in the treatment of multiple myeloma: a clinical study of 110 patients in China.

Li Y, Hou J, Wang D, Fu W, Yuan Z, Chen Y, Tao Z. Li Y, et al. Among authors: fu w. Leuk Lymphoma. 2006 Dec;47(12):2593-600. doi: 10.1080/10428190600955753. Leuk Lymphoma. 2006. PMID: 17169804

9

[Bortezomib in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma].

Yuan ZG, Hou J, Zhou F, Fu WJ, Chen YB, Xi H, Yang SL. Yuan ZG, et al. Zhonghua Xue Ye Xue Za Zhi. 2006 Oct;27(10):653-5. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 17343194 Chinese.

10

[The effect of cyclin D2 shRNA on the proliferation and apoptosis of LP-1 cell].

Guo C, Hou J, Chen YB, Jin HY, Fu WJ, Yuan ZG, Wang DX. Guo C, et al. Zhonghua Xue Ye Xue Za Zhi. 2006 Oct;27(10):666-9. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 17343197 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,307 results

Search Page

Filters